Plain-English translation of NCT07592962 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are trying to better understand who is at risk for stroke and cancer by screening a large, diverse group of adults in Lishui City. Depending on which group you join, you may receive advanced imaging scans of your head and neck, specialized blood tests that look for early cancer signals, or tests that measure how your liver is functioning. The goal is to catch these diseases early, when they're most treatable.
Stroke and cancer are major health threats, especially in communities with limited access to healthcare. This study wants to identify which people are at highest risk so doctors can step in earlier with prevention and treatment — rather than waiting for serious symptoms to appear.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of three groups. Depending on your group, you'll complete a series of non-invasive tests — which might include brain and neck imaging, special blood tests to screen for cancer risk, ultrasounds of your neck arteries, or tests to check your liver health. Most appointments involve imaging or blood draws that take a few hours. The study team will follow up with you over time to track your health and see if the screening tests help catch problems early.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China
Sponsor
The Fifth Affiliated Hospital of Wenzhou Medical University & Lishui Central Hospital
Enrollment target
~4,500 participants
Started
May 2026
Primary completion
May 2036
Age range
30 Years – 80 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jingping Sun, PhD
The Central Hospital of Lishui City
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.